NAMSA is a leading global CRO specializing in medical device and IVD development, offering comprehensive services from preclinical research to regulatory submissions and market access.
NAMSA is a premier global Contract Research Organization (CRO) dedicated to advancing medical device and In Vitro Diagnostic (IVD) innovation and safety worldwide. With over 50 years of experience, NAMSA supports over 3,000 companies annually, from startups to multinationals, in navigating the complex regulatory landscape. Their extensive expertise covers the entire product lifecycle, including strategic consulting, preclinical research, clinical trials, biological safety testing, and market access. Leveraging a team of 1,400+ professionals across North America, Europe, and Asia, NAMSA provides unparalleled support for regulatory submissions to agencies like the US FDA and EU Notified Bodies. They offer specialized services such as US FDA consulting (510(k), PMA, De Novo), EU MDR & IVDR consulting, biological safety assessments, and market research. Their state-of-the-art, GLP-compliant facilities conduct over 118,000 tests annually, ensuring devices are safe, effective, and compliant with global regulations. NAMSA's integrated approach ensures clients receive tailored solutions, from initial concept to commercialization. They are committed to helping clients shorten time-to-market, reduce costs, and achieve successful product launches by providing deep industry knowledge and client-focused service.
About
**Who they are** NAMSA is a global Contract Research Organization (CRO) focused on medical device and In Vitro Diagnostic (IVD) development. They offer a comprehensive suite of services designed to support clients throughout the entire product lifecycle.
**Expertise & scope** * Specializes in medical device and IVD development. * Services span preclinical research, regulatory submissions, and market access. * Focuses on Usability / Human Factors Engineering.
**Reputation / proof points** * Leading global CRO.
Additional information
NAMSA's approach to Usability / Human Factors Engineering is integrated into the broader medical device development process. Buyers can expect a structured engagement that moves from initial research through to regulatory compliance and market entry. The firm's expertise in navigating complex regulatory landscapes is a key consideration for companies seeking to bring innovative medical technologies to market efficiently and safely. Their comprehensive service model aims to streamline the development pathway, reducing potential delays and ensuring adherence to global standards.
Key Highlights
Global CRO specializing in medical device and IVD development.
Source
“NAMSA is a leading global CRO specializing in medical device and IVD development”
Offers comprehensive services from preclinical research to regulatory submissions and market access.
Source
“offering comprehensive services from preclinical research to regulatory submissions and market access.”